Australia markets closed

KORU Medical Systems, Inc. (KRMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.19000.0000 (0.00%)
As of 11:50AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 102.00M
Enterprise value 94.96M
Trailing P/E 398.47
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.50
Price/book (mrq)5.01
Enterprise value/revenue 3.33
Enterprise value/EBITDA -10.10

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-51.01%
S&P500 52-week change 321.08%
52-week high 34.4800
52-week low 31.9780
50-day moving average 32.1828
200-day moving average 32.3793

Share statistics

Avg vol (3-month) 398.23k
Avg vol (10-day) 381.44k
Shares outstanding 546.57M
Implied shares outstanding 646.57M
Float 831.97M
% held by insiders 16.37%
% held by institutions 157.60%
Shares short (15 Apr 2024) 41.15M
Short ratio (15 Apr 2024) 47.92
Short % of float (15 Apr 2024) 44.71%
Short % of shares outstanding (15 Apr 2024) 42.47%
Shares short (prior month 15 Mar 2024) 4994.53k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -48.18%
Operating margin (ttm)-30.58%

Management effectiveness

Return on assets (ttm)-18.13%
Return on equity (ttm)-53.18%

Income statement

Revenue (ttm)28.52M
Revenue per share (ttm)0.62
Quarterly revenue growth (yoy)-2.20%
Gross profit (ttm)N/A
EBITDA -9.4M
Net income avi to common (ttm)-13.74M
Diluted EPS (ttm)-0.3000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.48M
Total cash per share (mrq)0.25
Total debt (mrq)4.45M
Total debt/equity (mrq)21.84%
Current ratio (mrq)4.55
Book value per share (mrq)0.45

Cash flow statement

Operating cash flow (ttm)-4.89M
Levered free cash flow (ttm)-2.39M